Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

Timothy M E DavisJocelyn J DrinkwaterWendy A Davis

Published in: Diabetes care (2024)

Measurement of lung function in type 2 diabetes could help optimize clinical management and improve prognosis, including addressing glycemic control in those with a very low FEV1%pred.

Keyphrases

glycemic control
type diabetes
lung function
phase ii
blood glucose
clinical trial
cystic fibrosis
chronic obstructive pulmonary disease
open label
weight loss
air pollution
insulin resistance
cardiovascular disease
depressive symptoms
metabolic syndrome
adipose tissue
study protocol
double blind